Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

A woman who privately purchased an injectable GLP-1 weight-loss medication is claiming it made her hair fall out and gave her ...

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.

Last week, Pfizer announced that it would no longer develop danuglipron, a daily GLP-1 weight-loss drug which investors were ...

Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

Blue Cross Blue Shield of Massachusetts, the state's largest health insurer, recently announced that it will roll back ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

Wellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...

Health and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using a GLP-1 to help her progress. The nurse initially kickstarted her wellness ...

Health and wellness influencer Janelle Rohner is receiving backlash after revealing that she’s been taking medication for ...